D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 173 Citations 145,778 1,049 World Ranking 165 National Ranking 112

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Myocardial infarction
  • Surgery

Christopher P. Cannon focuses on Internal medicine, Myocardial infarction, Cardiology, TIMI and Surgery. Acute coronary syndrome, Coronary artery disease, Clopidogrel, Percutaneous coronary intervention and Heart failure are among the areas of Internal medicine where the researcher is concentrating his efforts. His Myocardial infarction research incorporates themes from Stroke, Atorvastatin and Hazard ratio.

His Cardiology study combines topics from a wide range of disciplines, such as Odds ratio and Platelet aggregation inhibitor. His studies in TIMI integrate themes in fields like Fibrinolytic agent, Sibrafiban and C-reactive protein. His Surgery research is multidisciplinary, relying on both Placebo and Kidney disease.

His most cited work include:

  • Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes (4782 citations)
  • Intensive versus moderate lipid lowering with statins after acute coronary syndromes. (3936 citations)
  • C-Reactive Protein Levels and Outcomes after Statin Therapy (1905 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Internal medicine, Cardiology, Myocardial infarction, TIMI and Acute coronary syndrome. His study on Clopidogrel, Unstable angina, Percutaneous coronary intervention and Coronary artery disease is often connected to In patient as part of broader study in Internal medicine. The concepts of his Cardiology study are interwoven with issues in Odds ratio and Aspirin.

His Myocardial infarction study incorporates themes from Stroke, Surgery and Hazard ratio. Christopher P. Cannon interconnects Fibrinolysis and Risk factor in the investigation of issues within TIMI. His biological study deals with issues like Atorvastatin, which deal with fields such as Statin.

He most often published in these fields:

  • Internal medicine (77.75%)
  • Cardiology (56.18%)
  • Myocardial infarction (43.67%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (77.75%)
  • Cardiology (56.18%)
  • In patient (12.06%)

In recent papers he was focusing on the following fields of study:

Christopher P. Cannon mostly deals with Internal medicine, Cardiology, In patient, Myocardial infarction and Diabetes mellitus. Internal medicine is a component of his Acute coronary syndrome, Atrial fibrillation, Percutaneous coronary intervention, Heart failure and Conventional PCI studies. Christopher P. Cannon usually deals with Acute coronary syndrome and limits it to topics linked to Ezetimibe and Placebo.

His research in Percutaneous coronary intervention intersects with topics in Regimen and Aspirin. His Cardiology research includes themes of Atherosclerotic cardiovascular disease and PCSK9. His study in Myocardial infarction is interdisciplinary in nature, drawing from both Stroke, Interquartile range, Randomized controlled trial and Hazard ratio.

Between 2017 and 2021, his most popular works were:

  • Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (1296 citations)
  • Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (1296 citations)
  • Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (219 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Myocardial infarction

Internal medicine, Diabetes mellitus, Acute coronary syndrome, Myocardial infarction and Cardiology are his primary areas of study. His studies deal with areas such as Type 2 diabetes and Type 2 Diabetes Mellitus as well as Internal medicine. Christopher P. Cannon combines subjects such as Clinical trial, MEDLINE, Kidney disease, Randomized controlled trial and Blood pressure with his study of Diabetes mellitus.

His study in Acute coronary syndrome is interdisciplinary in nature, drawing from both Coronary artery disease, Ezetimibe, Clinical endpoint, Metabolic syndrome and Clopidogrel. His studies deal with areas such as Young adult, Interquartile range and Cohort as well as Myocardial infarction. His research on Cardiology focuses in particular on Heart failure.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Lars Wallentin;Richard C. Becker;Andrzej Budaj;Christopher P. Cannon.
The New England Journal of Medicine (2009)

6971 Citations

Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

Christopher P. Cannon;Eugene Braunwald;Carolyn H. McCabe;Daniel J. Rader.
The New England Journal of Medicine (2004)

5959 Citations

Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation

Marc S. Sabatine;Christopher P. Cannon;C. Michael Gibson;Jose L. López-Sendón.
The New England Journal of Medicine (2005)

2684 Citations

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

William B. White;Christopher P. Cannon;Simon R. Heller;Steven E. Nissen.
The New England Journal of Medicine (2013)

2602 Citations

Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes

Elliott M. Antman;Milenko J. Tanasijevic;Bruce Thompson;Mark Schactman.
The New England Journal of Medicine (1996)

2444 Citations

Predictors of hospital mortality in the global registry of acute coronary events.

Christopher B. Granger;Robert J. Goldberg;Omar Dabbous;Karen S. Pieper.
JAMA Internal Medicine (2003)

2439 Citations

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Christopher P. Cannon;William S. Weintraub;Laura A. Demopoulos;Ralph Vicari.
The New England Journal of Medicine (2001)

2433 Citations

C-Reactive Protein Levels and Outcomes after Statin Therapy

Paul M Ridker;Christopher P. Cannon;David Morrow;Nader Rifai.
The New England Journal of Medicine (2005)

2382 Citations

TIMI Frame Count A Quantitative Method of Assessing Coronary Artery Flow

Gibson Cm;Cannon Cp;Daley Wl;Dodge Jt.
Circulation (1996)

2271 Citations

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

James A. de Lemos;David A. Morrow;Jane H. Bentley;Torbjørn Omland.
The New England Journal of Medicine (2001)

1985 Citations

Best Scientists Citing Christopher P. Cannon

Deepak L. Bhatt

Deepak L. Bhatt

Brigham and Women's Hospital

Publications: 614

Roxana Mehran

Roxana Mehran

Icahn School of Medicine at Mount Sinai

Publications: 347

Gregg C. Fonarow

Gregg C. Fonarow

University of California, Los Angeles

Publications: 338

Harvey D. White

Harvey D. White

Auckland City Hospital

Publications: 310

Matthew T. Roe

Matthew T. Roe

Duke University

Publications: 308

Dominick J. Angiolillo

Dominick J. Angiolillo

University of Florida

Publications: 279

Eric D. Peterson

Eric D. Peterson

Duke University

Publications: 277

Gregg W. Stone

Gregg W. Stone

Columbia University Medical Center

Publications: 268

Keith A.A. Fox

Keith A.A. Fox

University of Edinburgh

Publications: 264

C. Michael Gibson

C. Michael Gibson

Beth Israel Deaconess Medical Center

Publications: 255

Christopher B. Granger

Christopher B. Granger

Duke University

Publications: 255

Shaun G. Goodman

Shaun G. Goodman

University of Toronto

Publications: 247

Gilles Montalescot

Gilles Montalescot

Université Paris Cité

Publications: 246

E. Magnus Ohman

E. Magnus Ohman

Duke University

Publications: 245

Stephen J. Nicholls

Stephen J. Nicholls

Monash University

Publications: 240

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.